Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
62
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Clinical observation of immune checkpoint inhibitors in the treatment of advanced pancreatic cancer: a real-world study in Chinese cohort

Danyang SunDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Junxun MaDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Jinliang WangDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Fan ZhangDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Lijie WangDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Sujie ZhangDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Guangying ChenDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Xiaoyan LiDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Wushuang DuDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
,
Pengfei CuiDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]
&
Yi HuDepartment of Oncology, Chinese PLA General Hospital, Beijing, China, [email protected]Correspondence[email protected]
 show all
Pages 1691-1700 | Published online: 11 Sep 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
  • ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
  • Bond-SmithGBangaNHammondTMImberCJPancreatic adeno-carcinomaBr Med J2012344e247622592847
  • MaWGilliganBMYuanJLiTCurrent status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyJ Hematol Oncol2016914727234522
  • HarveyRDImmunologic and clinical effects of targeting PD-1 in lung cancerClin Pharmacol Ther201496221422324690569
  • TopalianSLTaubeJMAndersRAPardollDMMechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapyNat Rev Cancer201616527528727079802
  • TopalianSLDrakeCGPardollDMTargeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurr Opin Immunol201224220721222236695
  • GengLHuangDLiuJB7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progressionJ Cancer Res Clin Oncol200813491021102718347814
  • OkudairaKHokariRTsuzukiYBlockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer modelInt J Oncol200935474174919724910
  • BrahmerJRTykodiSSChowLQSafety and activity of anti-PD-L1 antibody in patients with advanced cancerN Engl J Med2012366262455246522658128
  • PatnaikAKangSPRascoDPhase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid TumorsClin Cancer Res201521194286429325977344
  • RoyalRELevyCTurnerKPhase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinomaJ Immunother201033882883320842054
  • Pico de CoañaYChoudhuryAKiesslingRCheckpoint blockade for cancer therapy: revitalizing a suppressed immune systemTrends Mol Med201521848249126091825
  • ZitvogelLGalluzziLSmythMJKroemerGMechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillanceImmunity2013391748823890065
  • SmythMJNgiowSFRibasATengMWCombination cancer immunotherapies tailored to the tumour microenvironmentNat Rev Clin Oncol201613314315826598942
  • EttingerDSWoodDEAisnerDLNon-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyJ Natl Compr Canc Netw201715450453528404761
  • JiangQXieMHeMAnti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancerOncotarget2017977672768329484143
  • DongZYZhongWZZhangXCPotential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung AdenocarcinomaClin Cancer Res201723123012302428039262

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.